Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aroc0003883990 | 312,921 | net | 29 May 2026 | tx 6+312,921 |
| Oncopeptides AB | 10,000 | net | 24 Feb 2017 | tx 1+10,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | PURCHASE | Aroc0003883990 | 200,000 | 0.48 SEK | first after silence |
| 15 Sept 2023 | PURCHASE | Aroc0003883990 | 47,530 | 0.52 SEK | first after silence |
| 04 Mar 2022 | PURCHASE | Aroc0003883990 | 36,900 | 0.54 SEK | |
| 14 Feb 2022 | PURCHASE | Aroc0003883990 | 17,785 | 0.75 SEK | |
| 03 Sept 2021 | PURCHASE | Aroc0003883990 | 5,353 | 1.87 SEK | |
| 01 Sept 2021 | PURCHASE | Aroc0003883990 | 5,353 | 1.87 SEK | first after silence |
| 24 Feb 2017 | PURCHASE | Oncopeptides AB | 10,000 | 46.00 SEK |
3 purchases reported after at least 12 months of silence — most recent on 29 May 2026.